======= HOXA7 =======
== Gene Information ==
* **Official Symbol**: HOXA7
* **Official Name**: homeobox A7
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3204|3204]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P31268|P31268]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=HOXA7&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HOXA7|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/142950|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis.
|Homeobox|
|negative regulation of monocyte differentiation|
|negative regulation of keratinocyte differentiation|
|negative regulation of epidermal cell differentiation|
|negative regulation of epidermis development|
|regulation of monocyte differentiation|
|negative regulation of cell-matrix adhesion|
|regulation of keratinocyte differentiation|
|negative regulation of epithelial cell differentiation|
|negative regulation of leukocyte migration|
|negative regulation of myeloid leukocyte differentiation|
|regulation of epidermal cell differentiation|
|negative regulation of cell-substrate adhesion|
|negative regulation of myeloid cell differentiation|
|regulation of epidermis development|
|embryonic skeletal system morphogenesis|
|RNA polymerase II distal enhancer sequence-specific DNA binding|
|negative regulation of leukocyte differentiation|
|regulation of cell-matrix adhesion|
|regulation of myeloid leukocyte differentiation|
|embryonic skeletal system development|
|negative regulation of hemopoiesis|
|regulation of epithelial cell differentiation|
|stem cell differentiation|
|regulation of leukocyte migration|
|regulation of cell-substrate adhesion|
|anterior/posterior pattern specification|
|regulation of myeloid cell differentiation|
|skeletal system morphogenesis|
|nuclear membrane|
|negative regulation of cell migration|
|regulation of leukocyte differentiation|
|negative regulation of cell adhesion|
|negative regulation of cell motility|
|embryonic organ morphogenesis|
|negative regulation of cellular component movement|
|angiogenesis|
|negative regulation of locomotion|
|transcription factor binding|
|regionalization|
|blood vessel morphogenesis|
|sequence-specific DNA binding|
|embryonic organ development|
|pattern specification process|
|negative regulation of immune system process|
|DNA-binding transcription activator activity, RNA polymerase II-specific|
|regulation of hemopoiesis|
|blood vessel development|
|skeletal system development|
|RNA polymerase II proximal promoter sequence-specific DNA binding|
|vasculature development|
|cardiovascular system development|
|embryonic morphogenesis|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|tube morphogenesis|
|regulation of cell adhesion|
|negative regulation of cell differentiation|
|tube development|
|regulation of cell migration|
|negative regulation of transcription by RNA polymerase II|
|circulatory system development|
|anatomical structure formation involved in morphogenesis|
|regulation of cell motility|
|negative regulation of developmental process|
|animal organ morphogenesis|
|embryo development|
|regulation of locomotion|
|regulation of cellular component movement|
|negative regulation of transcription, DNA-templated|
|negative regulation of multicellular organismal process|
|positive regulation of transcription by RNA polymerase II|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|DNA-binding transcription factor activity, RNA polymerase II-specific|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|regulation of immune system process|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|regulation of cell differentiation|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|-1.94|
|[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|2.04|
|[[:results:exp93|DABN racemic mixture R03 exp93]]|2.04|
|[[:results:exp507|Monensin 0.3μM R08 exp507]]|2.07|
|[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|2.08|
|[[:results:exp244|SB743921 0.001μM R05 exp244]]|2.28|
|[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.52|
|[[:results:exp33|Rotenone 2μM R00 exp33]]|3.5|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9856
* **Expression level (log2 read counts)**: -2.84
{{:chemogenomics:nalm6 dist.png?nolink |}}